These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1059269)

  • 1. [Cytostatic disease (problem of drug-induced agranulocytoses)].
    Vorob'ev AI; Brilliant MD; Baranov AE
    Ter Arkh; 1975; 47(6):3-11. PubMed ID: 1059269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolutionary aspects of the picture of pulmonary pathology in the course of chronic blood diseases (a correlation with cytostatic treatment)].
    Spanedda R; Romanini D; Cinotti A
    Riv Emoter Immunoematol; 1979; 26(1-2):30-8. PubMed ID: 298945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor-induction through cytostatic agents in man].
    Hunstein W; Rehn K
    Dtsch Med Wochenschr; 1975 Jan; 100(4):155-8. PubMed ID: 1053991
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute myelogenous leukemia in myelomatosis].
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 6. [Can cytostatic agents cause cancer?].
    Schaberg A; Gorsira MC
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1433-5. PubMed ID: 4506858
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation and drug therapies, and leukemia.
    Potolsky A; Creger WP
    Annu Rev Med; 1973; 24():75-82. PubMed ID: 4514215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side-effects of cytostatic and immunosuppressive therapy].
    Hartwich G
    Fortschr Med; 1973 Mar; 91(9):357-62. PubMed ID: 4633019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukaemia on myeloma.
    Br Med J; 1971 Mar; 1(5749):568-9. PubMed ID: 5278923
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlymphocytosis in a case of busulfan-induced medullar aplasia in chronic myeloid leukemia. Chromosome and functional study].
    Negrini AC; Azzolini A; Bertocchi I; Dolcino G
    Pathologica; 1967; 59(879):407-10. PubMed ID: 5273096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Myeloma and myelo-monocytic leukemia. Role of melphalan].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golener C
    Nouv Presse Med; 1973 Dec; 2(44):2958. PubMed ID: 4521337
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemic acute leukemia.
    Holland JF
    N Engl J Med; 1970 Nov; 283(21):1165-6. PubMed ID: 5273283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golenzer C; Adotti F; Dryll A; Roujeau J
    Pathol Eur; 1973; 8(4):287-98. PubMed ID: 4523953
    [No Abstract]   [Full Text] [Related]  

  • 18. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
    Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
    Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple myeloma terminating in leukemia].
    Manor Y; Steiner Z; Klajman A; Rozenszajn A
    Harefuah; 1978 Feb; 94(3-4):115-9. PubMed ID: 275198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.